Complement receptor immunoglobulin: a control point in infection and immunity, inflammation and cancer

Bibliographic Details
Published in:	Swiss Medical Weekly
Main Authors:	Annabelle Grace Small, Marwah Al-Baghdadi, Alex Quach, Charles Hii, Antonio Ferrante
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2016-03-01
Subjects:	Cancer CRIg-Fc fusion protein CRIg/VSIG4/Z39Ig cytokines dendritic cells infection and immunity
Online Access:	https://www.smw.ch/index.php/smw/article/view/2171

Similar Items

Neutrophils Require Activation to Express Functional Cell-Surface Complement Receptor Immunoglobulin
by: Annabelle G. Small, et al.
Published: (2022-03-01)

Human Dendritic Cells Express the Complement Receptor Immunoglobulin Which Regulates T Cell Responses
by: Usma Munawara, et al.
Published: (2019-12-01)

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy
by: Xia Zhou, et al.
Published: (2022-09-01)

CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells
by: Xiaomei Yuan, et al.
Published: (2017-11-01)

Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice
by: Hong Gao, et al.
Published: (2022-02-01)

Structural biology of complement receptors
by: Jorge Santos-López, et al.
Published: (2023-09-01)

Struktur dan Cara Berpikir Matematika melalui Framework Connections, Recognition Patern, Identifying Similarities and Differences and Generalising (CRIG)
by: Iyon Maryono, et al.
Published: (2024-11-01)

CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA
by: Shangshu Nie, et al.
Published: (2024-12-01)

V-Set and Immunoglobulin Domain-Containing 1 (VSIG1), Predominantly Expressed in Testicular Germ Cells, Is Dispensable for Spermatogenesis and Male Fertility in Mice
by: Yena Jung, et al.
Published: (2021-04-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
by: Fabian Bohländer, et al.
Published: (2021-12-01)

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
by: Sang Youb Han, et al.
Published: (2022-07-01)

VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice
by: Sang Youb Han, et al.
Published: (2026-04-01)

Editorial: Immunoglobulin Glycosylation Analysis: State-of-the-Art Methods and Applications in Immunology
by: Irena Trbojević-Akmačić, et al.
Published: (2022-05-01)

Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
by: Chiara Elisabeth Geyer, et al.
Published: (2021-05-01)

B7 Family Molecule VSIG4 Regulates Pulmonary Anti-Influenza Immune Responses via C-Type Lectin Signal Pathway
by: Jianxin Zhu, et al.
Published: (2025-10-01)

The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
by: Sang Youb Han, et al.
Published: (2023-01-01)

Art of innovating in the arts: Disentangling determinants of technological and symbolic innovations in creative industries— Evidence from Canadian museums
by: Paulin Gohoungodji, et al.
Published: (2025-11-01)

CD32 Ligation Promotes the Activation of CD4+ T Cells
by: María Pía Holgado, et al.
Published: (2018-11-01)

The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway
by: Jie Shen, et al.
Published: (2025-05-01)

VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1
by: Zongfu Pan, et al.
Published: (2025-02-01)

Gut lumen-leaked microbial DNA causes myocardial inflammation and impairs cardiac contractility in ageing mouse heart
by: Hong Gao, et al.
Published: (2023-07-01)

Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab
by: Nicole Osborne, et al.
Published: (2025-12-01)

Perspective view of allogeneic IgG tumor immunotherapy
by: Ying Liu, et al.
Published: (2024-03-01)

Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells
by: Oliver T. Burton, et al.
Published: (2018-06-01)

VSIG4 Promotes Tumour‐Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway
by: Jiafeng Liu, et al.
Published: (2025-05-01)

Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus
by: Zoltán Bánki, et al.
Published: (2019-02-01)

On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
by: Kevin Plattner, et al.
Published: (2023-03-01)

Expression and existence forms of mast cell activating molecules and their antibodies in systemic lupus erythematosus
by: Yuping Wang, et al.
Published: (2022-02-01)

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
by: Najibeh Shekari, et al.
Published: (2023-11-01)

B7 Family Molecule VSIG4 Regulates Intestinal Anti-<i>Enterohemorrhagic Escherichia coli</i> Immunity by Altering Gut Flora Diversity
by: Zhili He, et al.
Published: (2021-08-01)

Structural Basis of VSIG3: The Ligand for VISTA
by: Xiaoxue Xie, et al.
Published: (2021-03-01)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
by: Zheng C, et al.
Published: (2023-06-01)

Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways
by: Chun-xia Shi, et al.
Published: (2020-05-01)

VSIG2 is associated with an immune-cold microenvironment and reduced response to PD-1 blockade in bladder cancer
by: Jihao Wu, et al.
Published: (2026-06-01)

Extracellular domain 1 of human FcγRI (CD64) identified as the binding site for anti-FcγRI antibodies
by: Tosca Holtrop, et al.
Published: (2025-12-01)

IgG subclasses and allotypes: from structure to effector functions
by: Gestur eVidarsson, et al.
Published: (2014-10-01)

Impact of Glycosylation on Effector Functions of Therapeutic IgG
by: Jean-Luc Teillaud, et al.
Published: (2010-01-01)

Immunoglobulin Fc heterodimer platform technology: From design to applications in therapeutic antibodies and proteins
by: Ji-Hee Ha, et al.
Published: (2016-10-01)

The evolution of flexibility and function in the Fc domains of IgM, IgY, and IgE
by: Rosaleen A. Calvert, et al.
Published: (2024-10-01)

IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
by: Yasmine Lamri, et al.
Published: (2020-12-01)